Research programme: HIV-1 inhibitors - Mymetics
Alternative Names: N-36E; S-291Latest Information Update: 16 Jul 2016
At a glance
- Originator Imperial College of Science, Technology and Medicine; Mymetics Corporation
- Class Peptides
- Mechanism of Action HIV envelope protein gp41 inhibitors; HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-1-infections in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-1-infections in USA
- 01 Apr 2003 Data presented at the 10th Conference on Retroviruses and Opportunistic Infections (CROI-2003) have been added to the Viral Infections antimicrobial activity section